Entitlement dispute: when things seem a little incomplete

Future New Developments Ltd v B & S Patente und Marken GmbH, an Intellectual Property Enterprise Court, England and Wales, ruling by Judge Richard Hacon last week, is a short extempore decision that was picked up only on the subscription-only Lawtel service. If it sounds a bit familiar, that's because an earlier matter arising out of this dispute was noted on the IPKat weblog, when it was established that the UK Intellectual Property Office was a "court" for the purposes of the Brussels I Regulation.

Future New Developments (FND), a Cayman Islands company, applied for summary judgment in its claim against a German company, B&S, concerning entitlement to a patent for energy-saving technology for use in fluorescent tubes. The initial applicant for the patent assigned the application to FND, following which the European Patent Office granted the patent in 2002.  However, in January 2002, FND's parent company issued a share mortgage in respect of FND's shares in favour of the patent's initial applicant. In March 2009, one of FND's directors purported to assign the patent to B&S and the UK Intellectual Property Office recorded B& as its registered proprietor.

A written resolution in February 2009 by FND's parent company purported to remove the director from his directorship and it appeared from official certificates issued in the Cayman Islands that the director had resigned in January 2009. An expert in Cayman Islands' law explained that, if the parent company was FND's sole shareholder (as was the case), it had the power to issue an ordinary resolution removing the director -- who, once removed, would have no further authority to assign the patent.  After the patent's assignment FND, which had paid €166,000 in renewal fees, maintained that the director had been lawfully removed from his directorship in February 2009 so that he had no legal authority to assign the patent, and that under Cayman law, even if he was a director, he would not have had authority without formal approval from FND's board of directors.

Although B&S did not appear at the hearing, a witness statement of one of its representatives did appear and submitted that (i) the validity of the assignment from FND to B&S fell to be determined under German law and that, in the absence of proper evidence, the court was not in a position to resolve it; (ii) the parent company had not been FND's sole shareholder at the relevant time, so the director's purported removal was invalid; (iii) the parent company had defaulted in paying under the share mortgage, which affected the ownership of the shares in FND; (iv) in January 2009 the original applicant's administrator had contracted with B&S to assign worldwide patent rights, including the patent at issue, for €15,000; (v) FND had not paid the fee for the patent's assignment, so that the agreement was a "pending contract" which could be disregarded once the original applicant became insolvent in 2008; (vi) the director had received no notice of the removal resolution, so his purported removal had no force in law and, finally, (vii) in January 2002, another individual had been appointed a director of FND under terms that breached the share mortgage agreement.

Judge Hacon granted the application. In his view:

* The witness statement of B&S's representative had also stated that the director's authority to assign was to be determined under the law of the Cayman Islands, and he gave no reason for stating why that position would not be recognised under German law. The court should not take into account his unrealistic expectation that the assignment would have encountered difficulties under German law, which did not amount to a defence.

* It was hard to determine from the documents what had happened regarding FND's shares during the relevant period. It seemed clear that the parent company had owned them in January 2002. Although a share mortgage had been issued, there was no evidence that the shares in FND had actually left the parent company, so that the director's directorship had validly been terminated.

* The share mortgage required written notice of default by the purchaser, i.e. the parent company, to be sent to the original applicant, and there was no evidence or suggestion that that had been done. If B&S's case was that no written notice had been sent, the court would have expected it to make an application in the Cayman Islands to rectify the position.

* The purported worldwide assignment mentioned by B&S was not produced in evidence.

* The evidence from the independent lawyer for B&S was that unfulfilled contracts ceased to have effect once a party became insolvent, but that the administrator "may" decide not to complete the contract -- but that was not quite what B&S's representative was contending. The original applicant's administrator could have dealt with the assignment of the patent application if the obligation to pay had not been fully satisfied. The expert had not indicated that the administrator had taken such a view, and the administrator himself had made no such comments in his evidence.

* The evidence showed that something was posted and faxed to the director on or about the date of the removal resolution, but did not show what was actually sent. The expert's unchallenged evidence was in any event that notice of removal was irrelevant to the removal's effectiveness.

* Whether another director of FND had been appointed did not affect whether the director at issue had been correctly dismissed. There was no evidence that the share mortgage had been breached, as that mortgage required the original applicant's prior written consent for such an appointment and no such consent had been adduced.

* None of B&S's representative's points raised any real prospect of success at trial. What's more, B&S hadn't paid any of the patent's renewal fees and the director had made no attempt to rectify his removal.

The takeaway message here seems to be that there is really no point in contesting litigation if your evidence is either not there at all or is not going to substantiate the points on which you are planning to rely. There's a somewhat unsatisfactory feeling about this case: did it only get as far as a hearing because the defendant half expected it to settle at the door of the court on a more favourable basis, this blogger wonders.

Federal Circuit Rules That Trial Court Should Stay Infringement Case Pending AIA Review

The Leahy-Smith America Invents Act established three new procedures for post-grant administrative patent challenges: inter partes review, post-grant review, and review under the transitional program for covered business method patents (“CBM”). One yet-unresolved issue concerning these administrative proceedings is their relation to, and coordination with, parallel federal court proceedings, such as infringement and declaratory judgment actions.

In a recent case, the U.S. Court of Appeals for the Federal Circuit ruled that a district court erred by not staying a pending infringement action while the defendant pursued a parallel CBM proceeding challenging the patents in suit on the grounds that the claimed inventions were not eligible under 35 U.S.C. § 101. Versata Software, Inc. v. Callidus Software, Inc., No. 2014-1468 (Fed. Cir. Nov. 20, 2014).

In September, 2012, Versata sued Callidus in the U.S. District Court for the District Delaware, alleging that Callidus infringed three patents. Callidus moved to transfer the case and also moved to dismiss the case. The district court denied both motions in May 2013. Callidus then filed a counterclaim alleging that Versata infringed three Callidus patents, and advised the district court that it planned to seek CBM review of the Versata patents. It filed a petition for review with the USPTO in August 2013 and sought a stay of the district court litigation. The district court deferred ruling on the stay motion until the USPTO acted on the pending petitions for review. In the interim, the court scheduled a Markman claim construction hearing and a 2015 trial date. After the USPTO granted the petition for review, the district court granted a stay as to one Versata patent, but not the two other patents asserted by Versata. Callidus appealed to the Federal Circuit.

On appeal, the Federal Circuit ruled that the district court erred in not granting a stay as to all three Versata patents, and that the denial was both an abuse of discretion and violated the AIA’s “more searching review” standard for stay motions. The Federal Circuit opinion approved the court’s earlier discussion of the consideration affecting stays in VirtualAgility Inc. v. Salesforce.com, Inc., 759 F.3d 1307 (Fed. Cir. 2014).

The AIA sets forth four factors for the district court to consider in deciding whether to stay litigation pending AIA review:

(A) whether a stay, or the denial thereof, will simplify the issues in question and streamline the trial; 

(B) whether discovery is complete and whether a trial date has been set; 

(C) whether a stay, or the denial thereof, would unduly prejudice the nonmoving party or present a clear tactical advantage for the moving party; and 

(D) whether a stay, or the denial thereof, will reduce the burden of litigation on the parties and on the court.

AIA § 18(b)(1). The Federal Circuit ruled that the district court erred in evaluating each of the four factors.

First, the district court erred by seemingly creating a “categorical rule” that an AIA proceeding will not simplify issues unless it covers all of the claims asserted in the lawsuit. The appeals court noted that:

But this type of categorical rule is inappropriate. Stays can be warranted even when a CBM proceeding does not address all asserted patents, claims, or invalidity defenses. Certainly this simplification factor weighs more strongly in favor of a stay when all of the litigated claims are undergoing CBM review. But there can still be a simplification of the issues when only some, but not all, of the claims asserted in litigation are challenged in a CBM review.

 Slip op. at 6. Among the factors that the district court should consider in evaluating this point are a comparison of the issues that the review would resolve versus the issues that would remain, the number of claims in suit included in the review, and the range of invalidity issues included in the review.

On the second factor, whether discovery is complete and a trial date has been set, the Federal Circuit also ruled that the district court erred. First, it noted that the district court must evaluate not just whether key litigation dates have been set, but how much more work remains to be done in the litigation before the trial date. In addition, this determination generally should be made at the time the motion for stay was filed. Given that the parties had not completed fact discovery, no deposition had taken place, and no expert discovery had been completed, the appeals court found that this factor strongly supported a stay.

The appeals court also disagreed with the district court that Callidus’s motion for stay would give it a tactical advantage, or unduly prejudice Versata. It noted that Callidus was seeking a stay of the entire litigation, including its infringement counterclaims. In addition, although the district court noted that Callidus’s motions to dismiss and transfer venue were considerations, apparently because the district court considered them to be vexatious, the Federal Circuit noted that parties have a right to file nonfrivolous motions relating to venue and challenging pleadings.

Finally, the Federal Circuit ruled that the district court misapplied the fourth factor, the reduced burden of litigation. The district court considered Callidus’s tactic of filing preliminary motions, noting that they actually increased the burden of litigation. The appeals court ruled that in evaluating this factor, however, 

[T]he district court clearly erred in evaluating the burden-of-litigation factor exclusively through this backward-looking lens. The correct test is one that focuses prospectively on the impact of the stay on the litigation, not on the past actions of the parties. When framed appropriately, it becomes clear that a stay will indeed reduce the future burdens of litigation.

 Slip op. at 13 (citations omitted). The court also observed that “simplification analysis under the first factor often points in the same direction as reducing the burden of litigation under the fourth factor.” Id. at 14.

As a result, the district court abused its discretion in denying Callidus’s request for a stay pending the CBM review proceeding. The Federal Circuit reversed and remanded with instructions to grant a stay.

The entire opinion is available HERE.

Standard Essential Patents Lose Ground

Colm Ahern

PatLit has received the following item from Spain, written by Colm Ahern (of Elzaburu, Madrid) including Colm's comment on the Advocate General's opinion on a reference to the Court of Justice (CJEU) of a case outlined in a previous post:

The Advocate General’s conclusions in Huawei v ZTE (C‑170/13) which were published today amount to a significant departure from the very strict conditions laid down by the BGH in the Orange Book case regarding standard essential patents and anti-trust law. They also vindicate the Commission’s position which has been openly critical of Orange Book. 

The Advocate General rejects the application of the rules established by the BGH in the Orange Book case, because that dispute concerned a de facto standard whereas the patent in suit concerns a standard which was agreed as part of a standardization process undertaken by the European Telecommunications Standards Institute in which both Huawei and ZTE had taken part. Huawei had agreed to provide licenses to competitors on fair, reasonable, and non-discriminatory terms (FRAND).

The BGH held that the seeking of a cessation injunction by a patent holder with a dominant position, would only constitute abuse of that position if the alleged infringer had made un unconditional and binding license offer which could not be limited to cases where patent infringement had been proven. By contrast the Advocate General places the burden on the patent holder to first send a notice letter setting out not only the alleged infringement but also the terms of license offer under FRAND conditions of a type normally used. The alleged infringer could then respond with a counter-offer setting out alternative terms. The patent holder could only seek an injunction if the counter-offer were held not to be serious and to constitute a mere delaying tactic. The alleged infringer could also reserve the right to later challenge both patent validity and the existence of infringement.

If the CJEU now accepts the Advocate General’s conclusions, the rights held by owners of SEP patents under the “Orange Book Standard” will be significantly curtailed.

ZTE-Huawei and FRAND ( Case C 170/13) - The Advocate General has spoken

Melchior Wathelet Senior

Melchior Wathelet junior

In the case ZTE-Huawei, the Düsseldorf District Court had referred a number of questions to the Court of Justice. It is seeking to ascertain whether — and, if so, in what circumstances — an action for infringement brought by the holder of a patent which is ‘essential to a standard developed by a standards body’ (standard-essential patent (SEP)) against a manufacturer of products which comply with that standard constitutes an abuse of a dominant position for the purposes of EU competition law where the patent holder has made a commitment to grant licences on FRAND terms.

In yesterdays opinion, Advocate General Melchior Wathelet proposes to respond as follows (cited from the press release:

Where the proprietor of a standard-essential patent (SEP) has made a commitment to a standards body to grant third parties a licence on fair, reasonable and non-discriminatory (FRAND) terms, it constitutes an abuse of a dominant position for that proprietor to request corrective measures or to seek an injunction against a company that has infringed the SEP (‘the infringer’)4 (an action which, if successful, may cause the products and services supplied by the offending company to be excluded from the markets covered by the standard), where it is shown that the SEP holder has not honoured its commitment even though the offending company has shown itself to be objectively ready, willing and able to enter into such a licensing agreement.
In order to honour that commitment and to avoid abusing a dominant position, the SEP holder must, before making a request for corrective measures or seeking an injunction, alert the infringer to the infringement at issue in writing, giving reasons, and specifying the SEP concerned and the way in which it has been infringed by that company, unless it has been established that the alleged infringer is fully aware of the infringement. The SEP holder must, in any event, present the alleged infringer with a written offer of a licence on FRAND terms and that offer must contain all the terms normally included in a licence in the sector in question, including the precise amount of the royalty and the way in which that amount is calculated.
The infringer must respond to that offer in a diligent and serious manner. If it does not accept the SEP holder’s offer, it must promptly present the latter with a reasonable counter-offer, in writing, in relation to the clauses with which it disagrees. An application for corrective measures or for an injunction does not constitute an abuse of a dominant position if the conduct of the infringer is purely tactical and/or dilatory and/or not serious.
If negotiations are not commenced or are unsuccessful, the conduct of the alleged infringer cannot be regarded as dilatory or as not serious if it requests that FRAND terms be fixed either by a court or by an arbitration tribunal. In that event, it is legitimate for the SEP holder to ask the infringer either to provide a bank guarantee for the payment of royalties or to deposit a provisional sum at the court or arbitration tribunal in respect of its past and future use of the patent.
Nor can an infringer’s conduct be regarded as dilatory or as not serious during negotiations for a licence on FRAND terms if it reserves the right, after entering into an agreement for such a licence, to challenge before a court or arbitration tribunal the validity, use and essential nature of that patent.
In taking legal action to secure the rendering of accounts, the SEP holder does not abuse a dominant position. It is for the national court in question to ensure that the measure is reasonable and proportionate.
In bringing a claim for damages in respect of past use of the patent, for the sole purpose of obtaining compensation for previous infringements of its patent, the SEP holder does not abuse a dominant position.

The full text of the Opinion can be found here.

No unitary patent before establishment of unified court, advises Advocate General

Advocate General Bot's combined Opinion today in Case C-146/13 Spain v Parliament and Council and C-147/13 Spain v Council was directed principally at Spain's challenges to the legality of Regulation 1257/2012 on the unitary patent. However, his stance -- which is likely to be accepted by the Court of Justice of the European Union -- also makes reference to the Unified Patent Court. This can be seen from the following extract of the Curia media release issued this morning:

Spain claims that the regulation [on the unitary patent] provides for a specific judicial regime for the European patent with unitary effect which is contained in the Agreement on a Unified Patent Court. It claims that the content of that agreement affects the Union’s powers and confers on a third party the power to determine unilaterally the application of the regulation. The Advocate General takes the view that the Court does not have jurisdiction to review the content of the Agreement on a Unified Patent Court in an action for annulment of the regulation. The Advocate General observes that the Agreement on a Unified Patent Court does not fall within any of the categories of acts the lawfulness of which is subject to judicial review by the Court. It is an intergovernmental agreement negotiated and signed only by certain Member States on the basis of international law. Moreover, the regulation does not approve an international agreement or implement such an agreement, but is intended to implement enhanced cooperation in the area of creation of unitary patent protection.  

Spain claims that the application of the regulation is absolutely dependent on the entry into force of the Agreement on a Unified Patent Court, and that the effectiveness of the power exercised by the European Union through the contested regulation thus depends on the will of the Member States which are party to the Agreement on a Unified Patent Court. The Advocate General states that the EU legislature provided for the establishment of a court having jurisdiction in respect of European patents with unitary effect, to be governed by an instrument setting up a unified patent litigation system for European patents and European patents with unitary effect. The EU legislature considered that the establishment of such jurisdiction was essential in order to ensure the proper functioning of the European patent with unitary effect, consistency of case-law and hence legal certainty. In the Advocate General’s view, the objective of the regulation is to ensure such proper functioning. It would be contrary to such principles to apply the contested regulation when the Unified Patent Court has not yet been established.  

The principle of sincere cooperation requires the participating Member States to take all appropriate measures to implement enhanced cooperation, including ratification of the Agreement on a Unified Patent Court, as such ratification is necessary for its implementation. By refraining from ratifying the Agreement on a Unified Patent Court, the participating Member States would infringe the principle of sincere cooperation in that they would be jeopardising the attainment of the Union’s harmonisation and uniform protection objectives. Moreover, the link between the regulation and the Agreement on a Unified Patent Court is such that it would have been inconsistent not to make the application of the contested regulation conditional on the entry into force of that agreement. 

FTC announces settlement with patent assertion entity MPHJ

Almost a year ago, the Federal Trade Commission initiated an investigation into the conduct of MPHJ Technology Investments LLC, a patent assertion entity which allegedly employed deceptive tactics to persuade small businesses to acquire licenses for technologies related to networked scanning systems. The FTC examined in detail the modus operandi of the company, observing that MPHJ typically targeted small companies (having between 20 and 99 employees) in specific sectors (e.g. veterinary services, lawn and garden services, building maintenance services, etc.), employing a three stage process to induce such businesses to conclude licensing agreements:

1.  MPHJ sent a letter in the name of one of its subsidiaries, identifying itself as the licensing agent for a specific set of patents (known as the Klein patents), deemed to cover computer management systems capable of transmitting electronic images, graphics, and/or documents through a communications network from a network addressable scanner, digital copier, or other multifunction peripheral to external devices, files, and applications. The letter, sent to ca. 16,465 small businesses in the US, alleged that the recipient was likely infringing the Klein Patents by using common office equipment (e.g. a digital copier/scanner/multifunction equipment), and stated that MPHJ was willing to initiate licensing negotiations. The letter also contained some distinctive features, such as the indication of a positive response by the industry to earlier licensing requests made by the patent assertion entity ("most businesses, upon being informed that they are infringing someone’s patent rights, are interested in operating lawfully and taking a license promptly" and “[m]any companies have responded to this licensing program in such a manner"), and the identification of a fair price for a license ($1,200 per employee), allegedly based on prior licensing negotiations.


2. In case of no response, most of the targeted businesses (over 10,000 of the original 16,465) received a second letter signed by MPHJ's counsel, the law firm Farney Daniels. The letter stated that "our client [has] reasonably assume[d] you have an infringing system and need a license [and] has referred the matter to [Farney Daniels]"; the law firm added that its representation of MPHJ, or of one of the patent assertion entity's subsidiaries, could involve litigation, but reiterated the willingness to enter into a licensing agreement.


3. The third letter, sent to almost 5,000 companies, was again signed by Farney Daniels' attorneys and contained a draft complaint related to an action for patent infringement that the law firm threatened to initiate, on behalf of MPHJ, within two weeks.

In its complaint, the FTC took issues with the allegedly deceptive, false and/or misleading statements contained in the three letters mentioned above. In particular, the FTC noted that, at the time of the sending of 7,366 first letters, MPHJ had not yet sold a single license for the Klein patents (and had concluded only one licensing agreement by the time it sent the following 1,077). The FTC also observed that different versions of the same letter contained different statements concerning the fair price calculated on the basis of the (non-existent) prior licenses. Further, the authority added that neither MPHJ nor Farney Daniels were, at the time of the sending of the third letters, ready to initiate legal actions for infringement of the Klein patents against the targeted businesses, and did not intend to promptly initiate such litigation. Thus, the FTC's complaint argued that such false and/or misleading statements constituted deceptive acts or practices affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act. MPHJ brought an action against the FTC in the Western District of Texas, alleging a violation of its First Amendment rights and of the Separation of Powers Doctrine; the action was dismissed in September. In the meanwhile, several states conducted parallel investigations into the deceptive tactics employed by MPHJ, employing different means to prevent the patent assertion entity and its counsel from persevering in such activities (see, for example, our previous posts here, here, and here).

On 6 November, the FTC announced that MPHJ and Farney Daniels have agreed to settle the charges. The FTC's proposed consent order, in addition to provisions on record-keeping, compliance reporting and notification, contains specific requirements meant to prevent the use of false and misleading statements in future letters sent by the respondents. In particular, the draft consent order would prevent MPHJ and Farney Daniels from making, in a patent assertion letter, any representation, expressly or by implication:

• that a particular patent has been licensed to a substantial number of licensees at particular prices or within particular price ranges, or any other representation concerning the results of licensing, sale, settlement, or litigation of a particular patent, unless such representation is non-misleading and based on reliable evidence, at the time the representation is made;


• about the licenses for a patent or the responses of recipients of a patent assertion letter, unless the representation is non-misleading and based on reliable evidence, at the time the representation is made;


• that MPHJ, its subsidiaries or counsel have taken any action with respect to the filing of a lawsuit, unless the representation is true and non-misleading;


• that MPHJ, its subsidiaries or counsel will take any action with respect to the filing of a lawsuit, unless at the time such representation is made, they have decided to take such action and possess and rely upon competent and reliable evidence sufficient to substantiate such statement.

Public comments on the proposed consent order are due, through this dedicated webpage, by Monday 8 December.

When a Delay turns into a Monster - T 0480/12

In the third game of the World Chess Championship in Sochi, challenger Viswanathan had put a  pawn on c7 quite early. Initially, the pawn did not look very dangerous but slownly tunred into a true monster pawn binding major parts of Carlsen's energy the longer the game lasted.

The crucial role of the seemingly harmless expression "data transmission delay" in the decision T0480/12 reminds me of this monster pawn of Viswanathan Anand. In the end, these words turned out to be as fatal as was the pawn for Magnus Carlsen:

Here is a quote from the grounds of opposition (emphasis added):

The feature "data transmission delay or latency" was introduced to replace "delay of data" during the examination procedure at which the latter had been regarded as unclear, because of leaving the reader in doubt as to the kind of processing referred to, e.g. processing delay, queuing delay or transmission delay (see communication of 4 November 2004, point 1.3). In the course of the opposition procedure the term "or latency" was deleted in the aim to overcome an objection as to added subject-matter. The respondent objected to the remaining feature "data transmission delay" for lack of clarity and argued that the term was no longer clear due to the deletion of "or latency".  

Moreover, the interpretation of the term "data transmission delay" on the basis of the description, see in particular paragraphs [0076], [0082] and [0083] was different from how this term was used by the skilled person. 

.......... 

While the appellant pointed out that the expression "data transmission delay" was clear in the light of the description of the patent by referring to paragraphs [0076], [0082] and [0083], the board agrees with the respondent that a claim has to be clear per se (see T 1129/97 dated 23 June 1998, point 2.1.2). However, when referring to "data transmission delay" in claims 1 and 7, in particular since the words "or latency" were removed from "data transmission delay", the skilled person would have an understanding of the expression different from the description. As is apparent from e.g. prior art document

A8: Rosado, Sosa C et al: Jitter compensation scheduling schemes for the support of real-time communications ,ICC 98, Conference Record, 1998 IEEE International Conference On Atlanta, GA, USA 7-11 June 1998, NEW YORK, NY, USA, IEEE, US, 7 June 1998, pages 885-890,

referred to by the respondent during oral proceedings, there are different types of delay like propagation delay, processing delay, queuing delay, transmission delay etc. (see e.g. section 2.1). Without further specification, the skilled person would interpret the expression "data transmission delay" in claim 1 to refer to this special type of delay rather than to the whole delay. The skilled  person would not understand claim 1 in a way that it is referred to more than the transmission of the data without further considering the description.

This means that:

• words used in the claims must have a clear meaning per se;
• the claim is unclear in cases where this meaning is modified when reading the claim in the context of the specification (which is always true to some degree...).

Looks like a blueprint for clarity attacks to virtually every amendment made after grant to this blogger!

Fleas, Lice, Flies and Late Filed Docoments - T 0584/09

The decision in the matter T 0584/09 has been issued almost one year ago but has not yet been sufficiently bemoaned in the blogosphere.

The patent in suit related to the use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.

While this blogger supposes that appellants popping up with late-filed documents may be as pesky as fleas, lice and flies for members of the technical board of appeal, only the former enjoy the benefit of the right to be heard.

In the decision T 0584/09, the board considers the documents 9 to 12 as late filed although they had been filed (but not admitted) in the 1st instance no less than 5 years prior to the date of the oral proceedings.

This is how the board justifies this surprising decision (emphasis added, translation from German):

3. Admissibility of documents in the legal proceedings 

3.1. Documents (9) and (12) 

3.1.1. These documents were filed by the opponent in the opposition proceedings with letters dated February 22 and October 2008, however, they were not admitted by the Opposition Division to the legal proceedings. 

3.1.2. Pursuant to Article 12(4) of the Rules of Procedure of the Boards of Appeal the Board (RPBA) has the power “to hold inadmissible evidence… which could have been already presented in the first instance proceedings or were not admitted, there” (see Supplement to the Official Journal EPO 1/2013, pages 39-49). 

3.1.3. As part of the examination of the decision of the Opposition Division not to admit documents into the legal proceedings, a Board of Appeal should only overrule the way in which the first instance has exercised its discretion if the Board comes to the conclusion that the first instance has exercised its discretion according to the wrong criteria, without taking into account the right criteria, or in an unreasonable way (see T 640/91, Official Journal EPO 1994, 918, issue 6.3. of the decision grounds). 

3.1.4. Based on the written decision of the Opposition Division as well as on the protocol of the Oral Proceedings it is presented clearly and concisely, that the admissibility of these documents was discussed (see pages 5 to 7 of the decision of the Opposition Division and issue 2 of the protocol of the Oral Proceedings). This was not contested by any party. 

It was emphasized in the contested decision, that these documents were presented with a delay and it was sufficiently reasoned, why these documents are not relevant. 

Hereby, the Opposition Division has applied the criterion of relevance on the document presented with a delay, as it is proposed in the Examination Regulations (see Guidelines for Examination in the European Patent Office, E-III 8.6, December 2007 Edition). 

As a consequence, the Opposition Division has sufficiently reasoned its discretion and exercised according to the right criteria. Whether or not the Opposition Division may have erred in the judgment of the relevance of the documents, as the appellant argued, is not of any relevance here and has not to be examined by the Board. 

3.1.5. Therefore, the Board has decided not to admit the documents (9) and (12) into the legal proceedings.

In brief, the Technical Board of Appeal argues that it has no discretion on its own to admit documents which have not been admitted in the first instance for good reasons.

The board confuses two points: the cited decision T 640/91, Official Journal EPO 1994, 918, issue 6.3. of the decision grounds relates to the question whether a refund of the appeal fees is justified because opposition division has violated the right to be heard by not admitting documents at a late stage and examines the way in which the first instance has exercised its discretion for this purpose.

According to the established (and hopefully still valid) case-law, documents filed with the grounds of appeal should be admitted unless there are indications that the late-filing amounts to a procedural abuse.

PatLit hopes that this decision remains isolated.

The file wrapper can be found here.

Nov. 10 Program To Explore Market-Based Alternatives To Patent Litigation

One approach to resolving or deterring patent threats, especially those posed by patent assertion entities or aggressive non-practicing entities, is the use of market-based alternatives to traditional litigation. If you are interested in learning more about this trend, consider attending an interesting program, "Toward Patent Non-Aggression: Market-Based Approaches to Deterring Legal Risks and Neutralizing Litigation," to be presented by the Washington Legal Foundation on Monday, Nov. 10, 2014, 2:00 p.m.-3:15 p.m. EDT (New York Time).

Click to Register for Webcast

In the spirit of their own technological innovation, small and large businesses have created “self-help” entities aimed at deterring and defending against costly patent litigation.  Each of the panelists and the organizations with which they are affiliated offer varied approaches to mutual cooperation, from cross-licensing to challenging questionable patents before the PTO.  The program will explore these private-ordering solutions function and discuss how they may be effective in reducing patent litigation, including non-practicing entities’ assertions and patent “privateering.”

Presenters will include:

Keith Bergelt
Chief Executive Officer
Open Invention Network

Kevin Jakel
Chief Executive Officer
Unified Patents, Inc.

Tim Kowalski
Senior Patent Counsel
Google Inc.

You can attend the program in person (if you happen to be in Washington) or via a webcast.  The program will take place at 2009 Massachusetts Ave., NW, Washington DC, and you can rsvp by email to Glenn Lammi at glammi@wlf.org.

The free webcast will be available live online at www.wlf.org.  You should pre-register for the webcast at this LINK.

Should All U.S. Patent Issues (Even Those Arising In State-Law Claims) Be Decided In Federal Court?

(The following is a guest contribution from Mark A. Cantor of Brooks Kushman P.C., a patent and technology law firm with offices in Detroit and Los Angeles. Mark is President of BK and Co-Chair of the firm's litigation practice. He can be contacted at mcantor@brookskushman.com.)

In the United States, we usually think of patent litigation as a federal court practice. However, significant patent issues can arise in IP-related state law claims. One question that arises frequently is whether those issues should be tried in state courts or federal court. Although the Supreme Court’s 2013 ruling in Gunn v. Minton, ___ U.S. ___, 133 S. Ct. 1059 (2013) restricted the types of state-law claims that are subject to federal court jurisdiction, the Federal Circuit may be poised to reassert jurisdiction to avoid potentially conflicting rulings in state and federal forums.

Federal Jurisdiction Under the Gunn

 

The federal courts exercise exclusive subject matter jurisdiction over claims for relief “arising under any Act of Congress relating to patents[.]” 28 U.S.C. § 1338(a). In the past, in addition to typical patent infringement actions, federal courts exercised “arising under” jurisdiction to a variety of state-law claims, including suits alleging breach of patent license agreements, defamation, and legal malpractice.

In Gunn, the Court held that a state-law claim “arises” under the Patent Act if patent issue implicated in a claim is: (1) necessarily raised, (2) actually disputed, (3) substantial, and (4) capable of resolution in federal court without disrupting the federal-state balance approved by Congress. Of particular importance is the requirement that the issue be “substantial.” As Gunn explained, it is not enough for the issue to be important to the outcome of the claim. Instead, an issue is substantial only if it is important “to the federal system as a whole.”

The state-law action in Gunn was for legal malpractice. The defendant attorney allegedly neglected to raise an argument in a patent infringement action that would have rebutted an alleged infringer’s argument that the patent was invalid due to a statutory bar. The Supreme Court held that while that argument was pivotal to the success of the malpractice claim, its “backward-looking” nature prevented federal jurisdiction:

Because of the backward-looking nature of a legal malpractice claim, the question is posed in a merely hypothetical sense: If Minton’s lawyers had raised a timely experimental-use argument, would the result in the patent infringement proceeding have been different? No matter how the state courts resolve that hypothetical “case within a case,” it will not change the real-world result of the prior federal patent litigation. Minton’s patent will remain invalid.

133 S. Ct. at 1068. For a more lengthy comment on Gunn, see “Gunn v. Minton: Supreme Court Pokes Another Hole In Exclusive Federal Jurisdiction Over Patent Rights,” SSRN No. 2232879 (Mar. 13, 2013).

Courts Apply Gunn To Expand State Court Jurisdiction

In applying Gunn, courts have focused on whether the patent law issue to be decided in the action is “backward-looking” or forward-looking. In other words, does the issue only relate to the state-law claim, or could it affect patent rights in future cases?

In Forrester Environmental Services, Inc. v. Wheelabrator Tech., Inc., 715 F.3d 1329 (Fed. Cir. 2013), the Federal Circuit applied Gunn to decline federal jurisdiction over a state court defamation action based on the defendant’s statements that the plaintiff was infringing three patents. The court noted that pre-Gunn cases in which it had recognized jurisdiction over disparagement claims “may well have survived the Supreme Court’s decision in Gunn.” 715 F.3d at 1334. Forrester’s claim did not survive, however, because any state court rulings on the scope or infringement of the patents would have no forward-looking affect: The patents all had expired and the defamatory statements referenced conduct in Taiwan, which would not be infringement in any event.

Like the Federal Circuit in Forrester, the majority of courts applying Gunn have failed to recognize federal question jurisdiction. However, unlike Forrester, many of those involved patents which are not invalid or expired. The courts tend to brush aside patentee arguments that any determination of patent law issues could have future preclusive effects.

In MDS (Canada) Inc. v. Rad Source Techs., Inc., 720 F.3d 833 (11th Cir. 2013), the court ruled that the Federal Circuit lacked appellate jurisdiction over a breach of license dispute that turned on whether the licensee’s product infringed three patents. The court held that the issue of patent infringement was not substantial. Notably, the court stated that infringement of the patent was not a substantial issue because, “Both the highly specialized nature of patent claims and the niche market for [the accused] blood irradiation devices suggest that the resolution of this issue is unlikely to impact any future construction of claims.” 720 F.3d at 842. The court did not mention that the licensed patents do not expire until 2022.

A review of other decisions applying Gunn reveal that courts have interpreted it to broadly discourage federal jurisdiction even when the underlying claim involves the validity or infringement of “live” patents. See, e.g., Bonnafant v. Chico’s FAS, Inc., Case No. 2:13-CV-893-FTM-29CM, 2014 WL 1664554 (M.D. Fla. Apr. 25, 2014) (whistleblower case lacked federal question jurisdiction when issue whether employee was instructed in infringe patent “will hardly call into question the entire federal trademark/patent system. Instead, it will require the application of a set body of law to the facts at hand.”); Airwatch LLC v. Good Technology Corp., No. 1:13-cv-2870-WSD, 2014 WL 1651964 (N.D. Ga. Apr. 24, 2014) (no federal jurisdiction over defamation action because infringement issue was “context-specific”); Transcardiac Therapeutics, Inc. v. Yoganathan, No. 1:13-CV-3089-AT, 2014 WL 1624086 (N.D. Ga. Feb. 28, 2014) (breach of contract, interference and fraud claims involving inventorship dispute lack federal question where inventorship was “not substantial in any relevant sense”).

Jang v. Boston Scientific: The Fed. Cir. Strikes Back?

More recently, the Federal Circuit has signaled that federal jurisdiction may continue over state-law claims in similar circumstances. In Jang v. Boston Scientific Corp., No. 2014-134, 2014 WL 4746002 (Fed. Cir. Sept. 16, 2014), the court considered whether it had appellate jurisdiction over a patent license dispute. The appeals court distinguished Forrester and stressed the risks of allowing other courts to rule on patent validity or infringement:

Permitting regional circuits to adjudicate questions of patent validity, for example, could result in inconsistent judgments between a regional circuit and the Federal Circuit, resulting in serious uncertainty for parties facing similar infringement charges before district courts within that regional circuit. Maintaining Federal Circuit jurisdiction over such contractual disputes to avoid such conflicting rulings is important to “the federal system as a whole” and not merely “to the particular parties in the immediate suit.” Gunn, 133 S.Ct. at 1066.

Jang, 2014 WL 4746002 at *3. As a result, the appeals court ruled that the patent issues raised by Jang’s breach of license claim were substantial and triggered “arising under” jurisdiction. This was true even though Jang’s patent had been invalidated as a result of reexamination proceeding. The Federal Circuit reasoned that jurisdiction must be assessed at the time an action is commenced, and since the patent only was invalidated later, federal jurisdiction attached to Jang’s claim.

The Jang decision suggests that the Federal Circuit, the regional circuit courts of appeals, and potentially state courts will continue to struggle with jurisdiction over patent issues arising in the context of state-law claims. Despite broad language in Gunn, it is likely that the Federal Circuit will tend to find jurisdiction in cases involving patents which remain in effect and where the application of patent law may affect future market activity or be the subject of future litigation.

Litigation-proof patents: a new title

Litigation-Proof Patents: Avoiding the Most Common Patent Mistakes is the title of a new book by this blogger's friend, US patent attorney and author Larry M. Goldstein. The book is so new that it was only published four days ago and no review copy has yet been procured. Having said that, the book's title alone qualifies it for a mention on the PatLit weblog.

According to the information available from the Amazon page from which it is being sold, it

" ... explains the principles of excellent patents, presents the ten most common errors in patents, and details a step-by-step method for avoiding these common errors. Specific patents are analyzed and shown to commit or avoid the most common patent mistakes. 

The book includes four chapters. 

• First, a step-by-step process for writing outstanding patents that capture all the innovative points of an invention and that avoid the most common patent mistakes. 

• Second, principles of litigation-proof patents, including characteristics of good patent claims, Key Claim Terms, patent value, seminal patents, and tips for writing patent applications. 

• Third, the ten most common mistakes that appear frequently in patents, and that destroy both patent quality and patent value. 

• Fourth, five patents that illustrate the concept of “litigation-proof patents”. 

These patents include the Hedy Lamarr frequency hopping patent from World War II, the patents for the board game Monopoly®, and the “slide-to-unlock” mobile phone patent that Apple asserted against Samsung ..." 

Perhaps unsurprisingly this book is intended for (i) anyone writing a patent who wants to achieve the highest-possible quality, (ii) patent evaluators who want to understand whether patents being reviewed suffer from value-destroying mistakes, and (iii) patent managers and heads of IP departments who are managing significant patent portfolios and want to understand the relative quality of their portfolios -- in other words, for everyone except patent litigators.

Litigation-Proof Patents turns out to be the second of three books the make up the author's Patent Quality Series (the first, True Patent Value, is reviewed by Neil Wilkof on IP Finance here and the third, Patent Portfolios: Quality, Creation, and Cost, will be published soon.

This blogger must reveal his personal prejudice at this moment: in his view, the thing that makes a patent litigation-proof is the sad reality that it isn't in anyone else's way so that (i) no-one ever infringes it and (ii) its validity is never challenged.  But that's another matter ...

Security for costs: a sensible approach

Guardian Barriers IP Ltd v Global Vessel Security, decided by Judge Hacon on 22 September in the Intellectual Property Enterprise Court (IPEC), England and Wales, is a useful little decision on security for costs. Again, this is an extempore ruling which has been picked up only on the increasingly useful Lawtel subscription-only case note service.

In short both parties, which sold anti-piracy devices for ships, were involved in a patent dispute [somewhat annoyingly Lawtel identifies them only as X and Y: it would cost little but add substantially to the value of the note if the parties' real names were used].  In these proceedings X sought an order for security of costs against Y to the tune of £50,000 [which happens to be the amount at which IPEC costs are capped]. Y's published accounts showed that they only had assets of approximately £1,000 and X, citing an email written by Y's solicitor which stated that their funds were limited, was concerned that, if Y lost the action, it would be unable to pay costs to the sum in question.  Y resisted the application for the order for security for costs, showing documents which, they said, showed prospective orders worth £4 million.  Since, if they lost, they wouldn't be ordered to pay X's costs until after the trial -- which was likely to take place in over a year's time -- they would by then have the funds to do so.  Meanwhile such money as they did have was needed for business growth.

Judge Hacon made the security for costs order.  In his view the prospective orders were not firm orders: most of Y's evidence consisted of documents showing that buyers were interested in the product, but there was no confirmation that they were actually going to place orders. What's more, even if Y did sell £4 million worth of products, there was no guarantee that they would make a profit. Looking at the firm and non-speculative side of things, on the evidence Y would not be in a position to pay X's costs if X succeeded at trial so it was appropriate to make an order.  However, security would be fixed at £17,000 (around one-third of the sum for which security was sought), this being the sum that had already been spent by X.  The issue would be reassessed at a case management conference.

It's always interesting to see how issues like this are handled, particularly since the need to give security for costs is frequently cited by SMEs as a reason for shying away from patent infringement litigation even when it is their own patent that is being allegedly infringed and they have received advice that their case is a strong one.  So far as one can see from the skeletal account of the dispute, Judge Hacon's decision here looks like a good, commonsense one.

Apple v Samsung in Japan: an English text

Patent litigation blossoming in Japan ...

In May there was a decision of the Japanese IP High Court on Apple v Samsung in which FRAND-based royalties were mentioned. The judgment, which was unsurprisingly delivered in Japanese, was released a month after it was rendered and has since become available to English speakers via this website; it took nearly five months to produce the translation, during the course of which the case settled.

Highlights of this case include the following:

Injunctions

Does a request for an injunction constitute an abuse of patent right? This issue is dealt with from page 17 onwards, one of the highlights being, on page 25, "Whether the respondent (Apple) has any intention of accepting a FRAND licence" (here and here).

FRAND licences

Apple alleged non-infringement of Samsung's patent and sought a declaratory judgment to confirm that Samsung was not entitled to damages from Apple's infringement (a summary of the claim is on page 3). From page 115 onwards the judgment focuses on FRAND (after deciding that Apple infringed Samsung's patent). From page 122 the text discusses whether the patentee should be allowed to seek damages and determination of the "patentee's claim for damages exceeding or equivalent to a FRAND-based royalty".

The court found that damages exceeding a FRAND-based royalty should not in general be allowed, though they may be appropriate in exceptional circumstances. Such circumstances would include situations in which the patentee proves that the alleged infringer is not a willing FRAND-based licensee. The court also decided that the damages equivalent to a FRAND-based royalty should be ordered unless it is significantly unfair to do so (cf the decision of the court of first instance). The court did not find any fact which demonstrated that it was unfair to disallow damages equivalent to a FRAND-based royalty, but found that Apple was a willing licensee which kept on negotiating with Samsung to obtain a licence by presenting specific royalty rates.

The amount of damages is discussed from 130 page onwards. The court analyses the percentage of contribution of the patent in suit in each product in issue, choosing to limit the aggregate royalty at 5% according to WCDMA and other patent pools. The summary of the actual calculation is on page 138 (D).

The court appreciates responses to the public consultation (Amicus Briefs) summarising the responses from page 139.

PatLit is grateful to a friendly reader for this information

Post-settlement infringement: Stretchline makes its mark

Stretchline Intellectual Properties Ltd v H&M Hennes & Mauritz UK Ltd is a Chancery Division, England and Wales, decision of Mr Justice Sales from 14 October. Sales J is not a judge who is normally associated with patent litigation, but this case did not require the application of any rocket science. The judgment was extempore and this case has been picked up only by the subscription-only Lawtel case note service.

This was an application by Stretchline to strike out parts of a defence filed by leading retail clothing company H&M to Stretchline's patent infringement claim. The patent itself related to a method of manufacturing tubular fabric for incorporation in the production of brassieres. Stretchline previously suspected that H&M was selling bras, made by other companies, which incorporated fabric that infringed its patent. and went to court accordingly. H&M's defence was invalidity plus a counterclaim for revocation. These proceedings were settled. Some years later, Stretchline received information causing it to suspect that H&M had returned to its errant ways. Stretchline made some test purchases from H&M stores. then commenced these proceedings. However, in its particulars of claim Stretchline pressed two inconsistent claims: it both sought to enforce the terms of the settlement agreement and alleged acts of infringement, which had been pleaded in the original proceedings, on the basis that H&M had repudiated the settlement agreement. H&M maintained that the patent had at all material times been invalid and denied breaching the settlement agreement.

Stretchline later sought the disclosure of certain documents from H&M in order to be able to decide what position to adopt as to the settlement agreement. Following that disclosure, Stretchline elected not to assert that the settlement agreement had been repudiated, but maintained that it was still valid and sought to enforce its terms. In this application, Stretchline sought to narrow the scope of the issues in dispute by striking out those parts of H&M's defence that sought to raise the issue of the patent's validity. Said Stretchline, the patent's validity had been determined by the settlement agreement, with the result that H&M was disabled from being entitled to allege invalidity. No said H&M, the settlement agreement did not have the effect of precluding the company from raising a defence and counterclaim based on invalidity.

Sales J granted Stretchline's application and struck out those parts of H&M's defence that sought to raise the issue of validity. Said the judge, on a proper interpretation of the agreement, all matters that were in dispute between the parties in the first action, including the issues raised by H&M in relation to the patent's validity, had been definitively settled by the terms of the agreement. What's more, the fact that Stretchline had originally advanced inconsistent pleadings did not mean it had waived its right to rely on the terms of the settlement agreement. Nothing in the way that Sretchline had pleaded or presented its case constituted a waiver of its right to rely on the agreement. In conclusion was in the interests of justice and the overriding objective to give effect to the settlement agreement and narrow the issues between the parties by striking out the relevant parts of H&M's defence.

It's good to see the court affirming the principle that voluntarily-made settlement agreements should be given the fullest effect, but one wonders what the drafting of the agreement in this case was like. The ideal settlement agreement will cover possible post-agreement outcomes, of which breach by an alleged infringer is one of the more predictable ones.  However, it can happen that a settlement agreement is agreed only at the cost of it having something of an open weave, with loosely-drafted terms that one or other party are less likely to agree to.

Broad Claims – supported if no indications to the contrary X ZR 19/11

The German Federal Court of Justice (BGH) had to decide on an appeal against the decision of the Federal German Patent Court to nullify a patent relating to stents having two interlacing meandering patterns as shown in the embodiment on the right-hand side.

 

The pattern looks somewhat complicated at first sight but a thorough inspection reveals that it is basically a superposition of horizontal meanders along the lines 13 and vertical meanders along the lines 9, wherein the latter vertical meanders are phase-shifted or – to use the words of the patent – “even” and “uneven” patterns in alternating arrangement. However, the limitation to “even” and “uneven” patterns in alternating arrangement did not figure in claim 1 as granted but only as a feature of the (single) embodiment of the invention.

The Hoge Raad and the Irish High Court had limited the claim to stents with “even” and “uneven” patterns in alternating arrangement by arguing that the documents as originally filed lacked any disclosure supporting the broader claim.

The BGH did not follow this line and judged that – to the contrary of what the other courts had found – the lack of any disclosure excluding stents without phase shift from the invention leads to the conclusion that these embodiments are disclosed as a part of the invention in the documents as originally filed.

The full text of the decision in German language can be accessed here.

Federal Circuit Clarifies Limits To "Sale" and "Offer For Sale" Infringement In Foreign Transactions

One perplexing issue facing companies involved in product development, manufacture and distribution in multiple jurisdictions is the potential extraterritorial effect of a nation’s patent laws. The U.S. Supreme Court has noted that, “[t]he presumption that United States law governs domestically but does not rule the world applies with particular force in patent law.” Microsoft Corp. v. AT&T Corp., 550 U.S. 437, 454-55 (2007). Yesterday, the Federal Circuit ruled that the sale of a patented component to a foreign buyer and delivered outside the U.S. is not a “sale” or “offer for sale” under the Patent Act, even if price negotations, customer support, and other activities took place in the U.S. Halo Electronics, Inc. v. Pulse Electronics, Inc., No. 2013-1472 and 1656 (Fed. Cir. Oct. 22, 2014). 

Halo was a patent infringement action involving patents for printed circuit board components manufactured and sold by the defendant, Pulse. Contract manufacturers used the Pulse components to assemble products for Cisco, which Cisco then distributed overseas. Although Cisco did not directly purchase the components, it negotiated with Pulse and other suppliers price ranges than would apply to components purchased by Cisco’s contract manufacturers. The actual sales contracts relating to the Pulse components alleged to infringe were negotiated and entered into outside the U.S., and the actual accused components were manufactured, delivered, and assembled into finished products outside the U.S. Nonetheless, significant activity occurred in the U.S.:

However, Pulse engaged in pricing negotiations in the United States with companies such as Cisco, and Pulse’s employees in the United States approved prices that its agents quoted to foreign customers when the quoted prices fell below certain thresholds. Pulse also engaged in other activities in the United States, including meeting regularly with Cisco design engineers, sending product samples to Cisco for pre-approval, attending sales meetings with its customers, and providing post-sale support for its products.

Slip op. at 4-5. The Federal Circuit ruled that this conduct was not infringement under 35 U.S.C. § 271. First, it was not a “sale” in the U.S.: 

Consistent with all of our precedent, we conclude that, when substantial activities of a sales transaction, including the final formation of a contract for sale encompassing all essential terms as well as the delivery and performance under that sales contract, occur entirely outside the United States, pricing and contracting negotiations in the United States alone do not constitute or transform those extraterritorial activities into a sale within the United States for purposes of § 271(a).

 Slip op. at 12.  Applying that standard to Pulse, the court found no infringement:

While Pulse and Cisco engaged in quarterly pricing negotiations for specific products, the negotiated price and projected demand did not constitute a firm agreement to buy and sell, binding on both Cisco and Pulse. Instead, Pulse received purchase orders from Cisco’s foreign contract manufacturers, which then firmly established the essential terms including price and quantity of binding contracts to buy and sell. Moreover, Pulse was paid abroad by those contract manufacturers, not by Cisco, upon fulfillment of the purchase orders. Thus, substantial activities of the sales transactions at issue, in addition to manufacturing and delivery, occurred outside the United States. Although Halo did present evidence that pricing negotiations and certain contracting and marketing activities took place in the United States, which purportedly resulted in the purchase orders and sales overseas, as indicated, such pricing and contracting negotiations alone are insufficient to constitute a “sale” within the United States.

 Slip op. at 12-13. For similar reasons, the court further held that the activity was not an “offer for sale,” which also is an act of infringement under § 271(a): 

An offer to sell, in order to be an infringement, must be an offer contemplating sale in the United States. Otherwise, the presumption against extraterritoriality would be breached. If a sale outside the United States is not an infringement of a U.S. patent, an offer to sell, even if made in the United States, when the sale would occur outside the United States, similarly would not be an infringement of a U.S. patent. We therefore hold that Pulse did not offer to sell the products at issue within the United States for purposes of § 271(a). 

Slip op. at 16. The full opinion is available HERE.

 

Now Ropes & Gray launches EU patent litigation site

PatLit has just been told about the Ropes & Gray Unitary Patent site, which promises to provide "up-to-date resources and information on developments surrounding the EU’s proposed Unified Patent Court". The site can be accessed here.

According to the firm's publicity, its team of qualified US and UK lawyers will regularly be updating the site, so visitors are invited to keep checking back when necessary for any developments.

As usual, readers' responses and evaluations are appreciated, particularly with regard to how law firms' European patent litigation web pages compare with one another.

Patents County Court survey: the results

Readers of this weblog may recall the publication of a request for assistance with regard to research undertaken by Kingsley Egbuonu into the Patents County Court for England and Wales. The fruits of Kingsley's research are summarised below, together with a link to his survey results. As Kingsley explains:

In 2010 Lord Justice Jackson published his final report (“The Jackson Review”) which made recommendations for, among other things, the reform of the Patents County Court for England and Wales (“PCC”). One of the recommendations relevant to the PCC was the implementation of the proposals in the Intellectual Property Court Users’ Committee (“IPCUC”) Working Group’s final report. Overall, the main objective of the reform package was to widen access to justice for small and medium-sized enterprises (“SMEs”) and private individuals in intellectual property (“IP”) disputes.

Following various changes to its rules of procedure, the PCC began operating under a new regime on 1 October 2010. The PCC witnessed further changes until 1 October 2013 when it was replaced by the Intellectual Property Enterprise Court (“IPEC”). However, in the year of its abolition, it was possible to find reasonable information which can be used to explain how the PCC’s new regime works in practice (on which see Angela Fox’s book on the IPEC) and/or to assess the extent to which the policy objectives of the reform have been achieved. My research, which was conducted between April 2013 and September 2013, attempted to do both.

The research primarily relied on a body of case law developed under His Honour Judge Birss QC (as he then was) and published by BAILII, legislation, statistics from the Ministry of Justice, existing literature, and empirical evidence from IP practitioners. The empirical evidence was obtained through an online survey which recorded 30 responses. The survey questions were framed based on the Jackson Review recommendations and issues raised in various Consultations relating to it (e.g. see the concerns raised IPCUC Working Group’s final report).

The survey results can be viewed or downloaded here.

The summary of my findings, as of 30 September 2013, are as follows:

1. Differentiation: Since 1 October 2010, there has been a clear distinction, in practice and procedures, between the PCC (continued by the IPEC) and the Patents Court or Chancery Division of the High Court. This helps the parties, typically claimants, make an informed decision about forum.

2. Costs capping and financial remedies limit:
• Generally, both measures were applied consistently, even in peculiar circumstances, in order to reassure prospective litigants. Sample of cases analysed found that average costs award was under £34,000 for liability trial and under £250,000 for damages.

• The costs capping regime has not deterred parties from incurring own costs above the relevant caps (e.g. see Lumos Skincare Ltd. v Sweet Squared Ltd & Others [2012] EWPCC 28 and Henderson v All Around the World Recordings Ltd & Another [2013] EWPCC 19).

3. PCC caseload:
• The statistics on the number of cases issued in the PCC are inconsistent. Nonetheless, it is generally clear that more cases have been issued post-October 2010 than ever before. This view may be supported with the rise in the number of PCC judgments published on BAILII.

• Further, the uptake of the small claims track was also encouraging: 16 cases were issued in 2012 and 28 as of July 2013. Lastly, the PCC entertained a variety of claims. Overall, the popularity of the PCC post-October 2010 is a clear evidence of success.

4. Profile of parties:
• A considerable number of cases involved SMEs and private individuals. Around 63 judgments published by BAILII (between November 2010 and 11 September 2013) involved an SME or private individual as a party. Arguably, this may well be the evidence to support the rationale behind the PCC reform.

• On the other hand, my research did not find substantial evidence to demonstrate that larger enterprises were abusing or disproportionately using the PCC; equally, there was no evidence to suggest that there was a flurry of litigation against large enterprises by SMEs as a result of the reforms.

• The PCC served private individuals and SMEs (represented or otherwise) and large enterprises equally.

5. Length of trial: Cases were generally listed and tried within two days; only a handful lasted longer. There was also an improvement in the length of time cases take to come to trial.

6. Transfers:
• My research did not find any evidence to demonstrate that there was a disproportionate number of litigation on transfers between the PCC and the High Court.

• Statistics revealed that just one case was transferred from the PCC to the High Court, whereas well over 10 were transferred to the PCC from other courts. The overwhelming majority of the PCC’s case load originated and remained there.

Verdict

Despite the little literature on the subject and difficulty in obtaining reliable statistics -- particularly on the number of cases and the profile of the parties involved -- my research concluded that the reforms generally succeeded. Active judicial case management and consistent application of the rules and case law were crucial to the success of the PCC.

The UK Intellectual Property Office, which should have better access to reliable data, is expected to publish its evaluation report on the PCC reforms this year.